No differences were apparent in terms of hepatic steatosis prevalence and surrogate indices of hepatic steatosis and fibrosis; moreover, glycometabolic parameters and β-cell function corrected for insulin resistance (disposition index) were comparable between the two groups. The gene discussed is INS; the disease is fibrosis.